ライフサイエンスコーパス: be selected for

1 els under which epimutability is expected to be selected for.

2 An optimal flow rate of 10 muL/min was selected for a continuous flow of warm media,and 10

3 he most promising compound in the series and was selected for a more in depth biological investigatio

4 with at least 5 mm of buccal bone dehiscence were selected for a flapless surgical approach to insert

5 Of these, 48 were selected for a full-text review, and 13 met the inc

6 n with acetaldehyde formed in model solution were selected for a proof-of concept experiment.

7 After weaning, 100 individuals were selected for a range of cognitive tests including a

8 A subset of patients (n = 98) were selected for a WES-only pipeline if the history was

9 e mutation having independently occurred and been selected for across domesticated species.

10 Temsirolimus has been selected for additional investigation in newly diag

11 tatic uptake time (the SUV from 60 to 65 min was selected for all scans), the second was uptake times

12 provement Program Participant Use Files 2015 were selected for all patients who underwent a 1-stage c

13 DS AND 191 child SUD cases (<5 years of age) were selected for analyses.

14 quality images of each eye from each session were selected for analysis and coregistered.

15 s of the Advanced Imaging for Glaucoma study were selected for analysis if they had 9 completed visit

16 One hundred seconds of tremor recording were selected for analysis in each patient.

17 amples were homogenized or specific proteins were selected for analysis of glycosylation.

18 tremes of aPWV (adjusted for blood pressure) were selected for analysis of leukocyte TL.

19 h quality SNPs (MAF >0.05; missing data <5%) were selected for analysis of this group of 58 accession

20 Thirty-three preferred terms (PTs) were selected for analysis, and significant RORs were mo

21 Two cancer types were selected for analysis, LGG (Brain lower grade gliom

22 binations of interim questionnaire responses were selected for analysis, representing the early perio

23 and those measurements taken at 14 to 40 wk were selected for analysis.

24 noncancerous areas in various human tissues were selected for analysis.

25 1 session, and images with the best quality were selected for analysis.

26 pecies biomass at assumed trophic levels 3-5 were selected for analysis.

27 Seventeen eyes of 10 patients were selected for analysis.

28 ammetry, while glassy carbon paste electrode was selected for analytical purposes.

29 tability-generating mechanisms, and how they are selected for and maintained.

30 as artificial antibodies with an ability to be selected for any target, aptamer development, unfortu

31 involved, as in other cases where inversions are selected for as a result of their effects on recombi

32 primary rat subpopulation of neuronal cells was selected for based on high, intracellular beta-III t

33 Twelve alfalfa genotypes that were selected for biomass under salinity, differences in

34 creating an array of 100 peptides that have been selected for broad capability to bind and/or kill v

35 ranscription waves; the type of behavior can be selected for by controlling gene activity and orienta

36 breeding programmes and are believed to have been selected for by human populations.

37 ession, suggesting that NF-kappaB activation is selected for by both somatic and viral events during

38 Eventually, the emulsion with 4.3 %wt salt was selected for catechin incorporation.

39 Of these Rca1beta was selected for characterization and overexpression stu

40 th the NP and HA gene segments from CIV-H3N2 was selected for characterization in ferrets.

41 The most effective was selected for cheese production in a 1L continuous sy

42 spectral region between 1734 and 1528 cm(-1) was selected for chemometric analysis.

43 with >70% reduction in HBV RNA and/or HBsAg were selected for chromatin immunoprecipitation analysis

44 should be made aware of their risk and could be selected for clinical trials for arresting progressio

45 -Cpa-Thi-Val-Asn-Cys)-Pro-d-Arg-NEt(2)) have been selected for clinical development for nocturia.

46 ve, specific, and efficient repeat (TsolR13) was selected for clinical testing.

47 iodontal treatment in the aforementioned RCT were selected for clinical and microbiological evaluatio

48 est value from the slope curve for each side was selected for comparison to minimize the effect of el

49 The previous last 10 ORH for LDLT were selected for comparison.

50 Traffic plumes were selected for comparison.

51 Eleven popular methods were selected for comprehensive comparison.

52 Nine proteins were selected for confirmation by flow cytometry or West

53 r interim analysis, we analysed patients who were selected for conservative management of an adnexal

54 In total 381 tests were selected for correct reference values.

55 Fifty-seven genes were selected for curation based on their frequent inclu

56 h advantageous levels of mtDNA mutations can be selected for depending on their cellular environment.

57 Consequently, this microRNA was selected for detailed experimental investigation.

58 edian 61.5 years) and control (n = 39) cases was selected for detailed neuropathological study.

59 total of 58,233 unique and informative SNPs were selected for developing the array.

60 Compound 1a (GRP-74915) was selected for development based on activity (EC50 = 0

61 00 patients were used in this study, and 400 were selected for development of the algorithm.

62 y in blocking TAS2R8-mediated bitterness and were selected for development.

63 Then, only one fragment was selected for digestion using a ((3)D) immobilized tr

64 t has been explicitly studied in detail have been selected for discussion.

65 otic organisms and 2502 viral proteomes that were selected for diversity and filtered by genome quali

66 Tanzania, Uganda, Zambia, and Zimbabwe) that were selected for DREAMS investment in 2015.

67 s, but define epigenetic field defects which are selected for during cancer progression.

68 Motile, particle-degrading taxa are selected for during early successional stages.

69 replication, and identifying which mutations are selected for during evolution is critical for virus

70 ome region, size, and structural preferences are selected for during their evolution and amplificatio

71 ense mutation has occurred independently and been selected for during at least 20 transitions between

72 ffer than the actin filament, and has likely been selected for during evolution to move large cargos.

73 ion, and indicate that this relationship has been selected for during the evolution of modern wheat.

74 Alleviation of this repression is selected for during invasive infections, leading to t

75 genetic variants that originated and likely were selected for during the passaging process, (ii) dir

76 secondary KIT mutations that arise (or that are selected for) during KIT TKI treatment.

77 dues in and near the active site and mutants were selected for E. coli growth on increasing concentra

78 Appropriate BSA transformations (BSA(alpha)) were selected for each measurement.

79 tations (the first mutations in a stem cell) are selected for early in cancer development inectoderma

80 e Leghorn (WL) and Cornish (Cor), which have been selected for egg and meat production, respectively,

81 he strongest delirium-related protein, which was selected for ELISA validation.

82 Two probiotic strains were selected for encapsulation (Lactobacillus plantarum

83 ch would be deemed to be of too high risk to be selected for engineered geologic storage, is adequate

84 whereby linked metabolic-epigenetic programs are selected for enhanced tumorigenic fitness during the

85 es in the sliding window, so they might have been selected for environmental adaptation.

86 the pamoic acid lead formulation, which has been selected for evaluation in a Phase 1 clinical trial

87 3 exhibited optimal in vitro properties and was selected for evaluation as a PET radioligand.

88 asis of its in vivo performance, [(99m)Tc]-1 was selected for evaluation in murine AAA, where MMP-12

89 Three lead compounds were selected for evaluation of in vivo efficacy against

90 Two control patients were selected for every case.

91 imaging (several characteristic absorbances were selected for every substance of interest) was used

92 Four drugs were selected for examination in vivo.

93 asma membrane, it remains unclear how cargos are selected for exosomal release.

94 tolerated dose was not reached; 500 mg daily was selected for expansion.

95 )SO + 0.5 M sucrose + 10% egg yolk solution) was selected for Experiment 2.

96 understood regarding how specific sequences are selected for export.

97 r infection of mosquitoes, a single var gene is selected for expression in the oocyst, and transcript

98 nes (glsA, regA and invA), and transformants were selected for expression of a hygromycin-resistance

99 roof-of-concept a design frequency of 10 GHz was selected for fabrication and experiment.

100 gest that IRE1alpha's conserved TMD may have been selected for features imparting a relatively muted

101 rterial graft: 5346; 3-arterial graft: 4941) were selected for final comparison.

102 s, suspected adulterated oregano samples can be selected for follow up authenticity testing.

103 Nine candidate diterpene synthase genes were selected for follow-up functional evaluation, of wh

104 Twenty-four variants were selected for follow-up in an independent dataset (U

105 clusion criteria outlined for assessment and were selected for full-text review and abstraction.

106 Of the 3273 abstracts reviewed, 131 were selected for full-text review, and 29 met the inclu

107 Of 5687 unique abstracts, 255 were selected for full-text review, and 57 studies, repr

108 n 194 potentially relevant citations, and 34 were selected for full-text review.

109 Of 9746 unique studies identified, 432 were selected for full-text review.

110 bclones are scored and a user defined number are selected for further analysis.

111 e transgenic event, designated MON88702, has been selected for further development of cotton varietie

112 One of these, HKlincR1, was selected for further characterisation.

113 entative of potential contamination sources, was selected for further characterization (fat, feed, ma

114 entification of an acceptable solid form, 5c was selected for further development for the treatment o

115 l)methyl)thio)ethyl)-3-phenylpropan-1-amine) was selected for further development.

116 Having the best balance of properties, 50 was selected for further evaluation.

117 crosomal stability, and selectivity for sEH, was selected for further in vitro and in vivo studies in

118 superior in vivo stability, (99m)Tc-PSMA-I&S was selected for further in vivo evaluation.

119 Among all, DDQ was selected for further investigation because of 1) its

120 Neoplasia Differentially Expressed (CRNDE), was selected for further investigation.

121 One representative compound of each cluster was selected for further lignin-specific assays, leading

122 ogue (1) with the best balance of properties was selected for further pharmacological evaluation.

123 From the 4 generated transgenic lines, 2 were selected for further analysis because they expresse

124 e material for clinicopathologic correlation were selected for further analysis, and clinical photogr

125 r whom more than two isolates were available were selected for further analysis.

126 had not been previously identified in potato were selected for further analysis.

127 ence, doses of 200 mg and 300 mg twice a day were selected for further assessment in the dose-expansi

128 1-ol (prenol) and 3-Hydroxy-2-butanone (AMC) were selected for further behavioral assays due to their

129 nts of total phenolics, anthocyanins and TSC were selected for further breeding purposes to provide h

130 resistance to killing, yfgA and sapA mutants were selected for further characterization.

131 riophages against K pneumoniae ST258 clade 1 were selected for further characterization.

132 Thirty-seven representative isolates were selected for further detailed characterization.

133 nd those with significant clinical relevance were selected for further ELISA validation in new cohort

134 o complement system and coagulant mechanism) were selected for further ELISA validation in new cohort

135 identified in the search and seven articles were selected for further evaluation after abstracts and

136 s (mAbs) expressing an IgG subtype Fc-domain were selected for further expansion and purification.

137 4-hydroxythiobenzamide moiety as H2S donor, were selected for further in vivo evaluation.

138 Therefore, DOTAP and DDA formulations were selected for further in vivo studies and were compa

139 approved by the FDA OHOP during this period were selected for further review, focusing on brand and

140 rated the highest yield and affinity, and so were selected for further sensor development.

141 The best inhibitors were selected for further studies.

142 ition proteins (PGRPs) PGRP-SB2 and PGRP-SC2 were selected for further study based on differential ex

143 tion and also changes in relation to obesity were selected for further validation by western blotting

144 Ten genes/gene clusters were selected for further validation, and their contribu

145 commonly overexpressed in both PDAC and IPMN were selected for further validation.

146 0 mg/kg weekly/every 2 weeks isatuximab dose was selected for future studies.

147 The S2093Y and S2093H mutants were selected for future use in stabilizing SAT2 vaccine

148 Forty representative S. mutans isolates were selected for genome sequencing from a large-scale e

149 yping-by-sequencing, 23,931 informative SNPs were selected for genome-wide analyses.

150 A viral load greater than 1000 copies per mL were selected for genotyping.

151 a single manufacturer and medium type should be selected for global monitoring efforts so that traini

152 stence of checkpoints at which QC substrates are selected for Golgi export and lysosomal degradation.

153 pared with placebo, in patients with AHF who were selected for greater potential benefit from vasopre

154 pancreatic ductal adenocarcinoma (PDA) cells were selected for growth in medium where extracellular a

155 the wild type (WT) mADA (Ea = 5.0 kcal/mol) were selected for HDX-MS experiments.

156 A fast recovery fast spin echo MR sequence was selected for high RF power, and an echo planar imagi

157 representative mcr-1-positive IncX4 plasmids were selected for high-throughput sequencing.

158 Specimens were selected for immunohistochemistry and FISH.

159 At least until stronger anticancer defenses are selected for in these species, females could achieve

160 's phenotype repeatedly throughout life, can be selected for in environments that do not stay constan

161 s the possibility that this variant may have been selected for in early Africa.

162 etin, with undefined cancer related targets, was selected for in silico target identification.

163 lantic marine terebellid Eupolymnia nebulosa was selected for in-depth chemical investigation.

164 eration times and lower asymptotic body mass were selected for in high-density environments even thou

165 ion genetic data suggest that MEFV mutations were selected for in individuals of Mediterranean decent

166 broad range of class I and II HLA molecules were selected for in vitro screening against PBMC sample

167 sis of their improved profile, these analogs were selected for in vivo pharmacodynamic (PD) and effic

168 on mastoparan-L, among which two (R1 and R4) were selected for in-depth analysis.

169 e H3N2, and one to two influenza B isolates, are selected for inclusion in the annual seasonal influe

170 Manuscripts were selected for inclusion based on expert opinion of w

171 o be relevant to the assessment criteria and were selected for inclusion in this assessment.

172 Thirteen of these were selected for inclusion in this assessment.

173 Of 555 studies identified, 77 were selected for inclusion plus 32 additional reference

174 Seventy-two candidate variables were selected for inclusion, and backward selection and

175 the first stage, 400 primary sampling units were selected for inclusion.

176 cates, 1,687 results were found, 60 of which were selected for inclusion; these sources yielded an ad

177 In genome-driven oncology, treatments are selected for individual patients on the basis of the

178 Five proteins were selected for initial verification by ELISA and thre

179 Two sites in each tumor were selected for intraoperative sampling on the basis o

180 ats presenting blood sugar levels >20 mmol/L were selected for investigation.

181 F power, and an echo planar imaging sequence was selected for its high heat-inducing gradients.

182 in-2-yl)vinyl tert-butyl carbonate (2APT-D6) was selected for its high potency.

183 Each rILSA was selected for its own individual purpose and applied

184 pots with greater than a 1.5-fold difference were selected for LC-MS/MS analysis and some confirmed b

185 As graft T cells have not been selected for leukemia specificity and frequently re

186 , at least in part, on which metastatic site is selected for localized therapy.

187 Four comparable studies were selected for meta-analysis.

188 terms of sensitivity and reproducibility and was selected for microarray development.

189 ss) of different patients of our institution were selected for model training and validation.

190 ample showing a high level of WSSV infection was selected for molecular analysis.

191 act precautions for drug-resistant organisms were selected for most activity sampling.

192 chniques, 169 were identified and 53 of them were selected for multivariate statistical analysis.

193 Three areas (CFAS I) were selected for new sampling two decades later (2008-2

194 358 patients were selected for next generation sequencing (NGS) with

195 rare and unclassified subtypes, 18 specimens were selected for next-generation sequencing (NGS) by a

196 igible civilian, noninstitutionalized adults were selected for NSDUH, and 51 200 completed the survey

197 dansyl-cadavarine-SMCC (SigmaMAb ADC mimic) were selected for optimization of the desulfuration reac

198 etate: 4.40, methanol: 5.10 and water: 9.0D) were selected for optimization.

199 From these efforts, analog 9 was selected for our initial in vivo study, which in com

200 y potentiation/residual Glu accumulation and were selected for our first iGlu (u) single-synapse stud

201 50% random sample of participants (N = 2468) was selected for ox-LDL measurements.

202 alcohol, and 5-hydroxymethylfurfural (HMF), were selected for oxidative upgrading catalyzed by a hie

203 New results suggest that vRNA is selected for packaging because psi nucleates assembly

204 otein were digested and proteotypic peptides were selected for parallel reaction monitoring (PRM) qua

205 ol weight (3399 g: P < 0.0001 vs target) and was selected for Part 2.

206 ydroxy-2-(3-hydroxyphenyl)-4H-chromen-4-one) was selected for pharmacokinetic studies.

207 /m(2) and carboplatin of AUC 4 mg/mL per min was selected for phase 2.

208 Compound 33 was selected for PK studies because it displayed balance

209 Next, an optimal model is selected for predicting the ACRHPs in 2014 of these c

210 that common miRNA candidate biomarkers could be selected for prion diseases in multiple species.

211 te actively determines which sensory signals are selected for processing in sensory brain regions.

212 Furthermore, it is unclear how antitoxins are selected for proteolysis by cellular proteases.

213 isothiocyanates, nitriles, and sulfides, and was selected for purification experiments.

214 Papers were selected for review in 3 categories: clinical trial

215 170 titles/abstracts screened, 99 full texts were selected for review, yielding one randomized contro

216 cles, databases, and reports identified, 103 were selected for review.

217 From 146 identified papers, 13 articles were selected for review.

218 nfants with and without bacterial infections was selected for RNA biosignature analysis.

219 Four capsidiol-related genes were selected for RT-qPCR analysis, two 5-epi-aristoloch

220 ed on the gene array results, specific genes were selected for RT-qPCR evaluation using species-speci

221 Five components were selected for score development, including mitral va

222 ve pathways in eight PDCs, 46 targeted drugs are selected for screening.

223 classified by structural similarity, and 15 were selected for secondary analyses addressing impacts

224 as a determinant for why an insulin granule is selected for secretion and may explain why newly synt

225 y identical in sequence, specific rRNA genes are selected for silencing during development via choice

226 r mechanisms by which one ancestral rDNA set is selected for silencing remain unclear.

227 When multiple targets are selected for sonication in a single treatment, unifo

228 602 patients with IPF and 3366 controls were selected for stage 1.

229 lenate, selenite, chromate, and perchlorate) were selected for study.

230 Five cultivars were selected for subsequent experiments to confirm thei

231 em, namely Elavl4, Nova2, Rbox1, and Rbfox2, were selected for subsequent functional studies in insul

232 n silico data analysis, antioxidant peptides were selected for subsequent identification in the diges

233 and differentiation equivalent to IndCl and were selected for subsequent in vivo evaluation for thei

234 older with at least one adnexal mass who had been selected for surgery or conservative management aft

235 On the basis of binding energy, 20 molecules were selected for synthesis and evaluation.

236 by nanoLC-ESI-QTOF-MS and thirteen peptides were selected for synthesis on the basis of their sequen

237 ticles of which nine (total, 1,994 patients) were selected for systematic review, and six (1,422 pati

238 elow the detection limit but due to ions not being selected for tandem mass spectrometry during the l

239 A newly constructed university building was selected for targeted assessment of changes in the l

240 s) and 154,281 known splicing junction sites were selected for targeted sequencing across five mouse

241 e from a previously MARV-infected individual were selected for testing as HCDR3 loop chimeras on the

242 prioritized or deprioritized; some of these were selected for testing.

243 filter, may determine how visual references are selected for the fly's internal compass.

244 , route of administration and/or formulation are selected for the new indication before their evaluat

245 generate new interesting phenotypes that can be selected for the improvement of vegetatively propagat

246 ablished as the recommended phase 2 dose and was selected for the dose-expansion phase.

247 ed dose was not reached; 500 mg once per day was selected for the expansion cohort.

248 Enasidenib 100 mg once daily was selected for the expansion phase on the basis of pha

249 STA wheat was selected for the second stage of the study to evalua

250 The fellow eye, without advanced AMD, was selected for the study.

251 One eye was selected for the study.

252 drocaffeic acid with hexanol and the best IL was selected for the synthesis of four other n-alkyl est

253 orophenyl (PFP) stationary phase combination was selected for the two-dimensional separation and frac

254 ferent chemical classes of SOPs, 17 pigments were selected for the analyses.

255 gh levels of deoxynivalenol and/or enniatins were selected for the cooking experiment.

256 Using these subgroups, 168 genes were selected for the development of 1000 linear support

257 The same variables, except for patient age, were selected for the distant metastases nomogram.

258 10,108 patients treated with lipiodol TACE, were selected for the efficacy analysis.

259 Zr-fum, based on different metal components, were selected for the external binding of various His-ta

260 RC01-class B cells from healthy human donors were selected for the generation of three BCR knockin mi

261 The 11000 compounds were selected for the HTS based on the known phenothiazi

262 Matched pairs were selected for the independent discovery (39 pairs) a

263 Eleven of 97 applicants were selected for the JPIA.

264 cases and 332 age- and sex-matched controls were selected for the matched analysis.

265 miR-424-5p and miR-29a-3p were selected for the network validation.

266 Arms B and D were selected for the phase II part of the study.

267 years who participated in The FUPRECOL Study were selected for the present analyses.

268 Of 369 records screened, 14 RCTs were selected for the qualitative and quantitative analy

269 62 papers were selected for the review.

270 Five blackberry cultivars were selected for the study ('Chester Thornless', 'Cacan

271 es' disease, defined by positive TRAb tests, were selected for the study, and their clinical data wer

272 teria, 2851 SLIT and 71 275 control patients were selected for the study.

273 m CATT and the 59 patients from DRCR.net who were selected for the switching analysis were similar in

274 m CATT and the 59 patients from DRCR.net who were selected for the switching analysis were similar in

275 Eight studies were selected for the systematic review; of these, seven

276 mination time points (DLI = 0.5, 9, or 48 h) were selected for the treatment based on the plasma/tumo

277 uggesting that mutations in cancer cells may be selected for their ability to exploit cell competitio

278 d 24-h dietary recall were available and who were selected for their exclusive intake or no intake of

279 s autochthonous of the Emilia Romagna region were selected for their notable performance in terms of

280 Two of these hits (I942 and I178) were selected for their robust and reproducible inhibito

281 A multiple-delivery-mode learning model was selected for this 3-month course in order to increas

282 or meta-analyses, and 5 reviews/guidelines) were selected for this review.

283 Those over 70-years old were selected for this study.

284 state cancer and minimal or no comorbidities were selected for this study.

285 zonia, Caatinga, Cerrado, Pampa and Pantanal were selected for this study.

286 A random sample of LTFU patients was selected for tracing by peer health workers.

287 test, strongest, or least damaged germ cells are selected for transmission to the next generation.

288 er, a mechanistic basis by which transcripts are selected for transport has not yet been identified.

289 st-corrected visual acuity from each patient was selected for treatment and was considered the study

290 Importantly, mixotrophy is selected for under a range of conditions even when mi

291 ocial group associated with one of the cases was selected for vaccination with 4CMenB and pharyngeal

292 y, the Tap efflux pump-encoding gene Rv1258c was selected for validation.

293 cation) involved in 10 disease-related genes were selected for validation by using quantitative real-

294 a samples of patients with CAV and therefore were selected for verification by quantitative reverse t

295 the conserved binding surface of Vpu TMD has been selected for weak binding to multiple targets.

296 rtions and deletions that can stochastically be selected for when targeting a tumor suppressor gene,

297 A preclinical development candidate was selected for which extensive in vitro and in vivo pr

298 e set of diverse B. distachyon diploid lines was selected for whole genome sequencing and high resolu

299 Twenty subjects representing all generations were selected for whole genome genotyping, of which eigh

300 thereafter, consistent with young adult men being selected for work after deportation but this selec